AI Adoption And Global Precision Medicine Will Expand Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
10 Aug 25
Updated
16 Aug 25
AnalystHighTarget's Fair Value
US$9.00
61.4% undervalued intrinsic discount16 Aug
US$3.47
1Y
6.4%7D
9.1%